Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Elite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressors.

Shasha D, Karel D, Angiuli O, Greenblatt A, Ghebremichael M, Yu X, Porichis F, Walker BD.

J Leukoc Biol. 2016 Dec;100(6):1425-1433. Epub 2016 Jul 12.

PMID:
27406996
2.

The CD8+ cell non-cytotoxic antiviral response affects RNA polymerase II-mediated human immunodeficiency virus transcription in infected CD4+ cells.

Blazek D, Teque F, Mackewicz C, Peterlin M, Levy JA.

J Gen Virol. 2016 Jan;97(1):220-4. doi: 10.1099/jgv.0.000326. Epub 2015 Oct 23.

3.

Discovery of another anti-HIV protein in the search for the CD8+ cell anti-HIV Factor.

Levy JA.

Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):7888-9. doi: 10.1073/pnas.1509324112. Epub 2015 Jun 17. No abstract available.

4.

Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques.

Chowdhury A, Hayes TL, Bosinger SE, Lawson BO, Vanderford T, Schmitz JE, Paiardini M, Betts M, Chahroudi A, Estes JD, Silvestri G.

J Virol. 2015 Sep;89(17):8677-86. doi: 10.1128/JVI.00869-15. Epub 2015 Jun 10.

5.

TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability.

Sperandio S, Barat C, Cabrita MA, Gargaun A, Berezovski MV, Tremblay MJ, de Belle I.

Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):E3392-401. doi: 10.1073/pnas.1500857112. Epub 2015 Jun 8.

6.

A comparison of elasticities of viral levels to specific immune response mechanisms in human immunodeficiency virus infection.

Showa SP, Nyabadza F, Hove-Musekwa SD, Magombedze G.

BMC Res Notes. 2014 Oct 20;7:737. doi: 10.1186/1756-0500-7-737.

7.

Predicting the impact of CD8+ T cell polyfunctionality on HIV disease progression.

Graw F, Regoes RR.

J Virol. 2014 Sep 1;88(17):10134-45. doi: 10.1128/JVI.00647-14. Epub 2014 Jun 25.

8.

Allo-antigen stimulated CD8+ T-cells suppress NF-κB and Ets-1 DNA binding activity, and inhibit phosphorylated NF-κB p65 nuclear localization in CD4+ T-cells.

Nagashima R, Kawakami F, Takahashi S, Obata F, Kubo M.

Viral Immunol. 2014 Aug;27(6):305-15. doi: 10.1089/vim.2013.0113. Epub 2014 May 20.

9.

The CD8-derived chemokine XCL1/lymphotactin is a conformation-dependent, broad-spectrum inhibitor of HIV-1.

Guzzo C, Fox J, Lin Y, Miao H, Cimbro R, Volkman BF, Fauci AS, Lusso P.

PLoS Pathog. 2013;9(12):e1003852. doi: 10.1371/journal.ppat.1003852. Epub 2013 Dec 26.

10.

Induction of a Soluble Anti-HIV-1 factor (s) with IFN-γ, IL-10, and β-Chemokine Modulating Activity by an Influenza-Bacterial Polyantigenic Mixture.

Rodríguez JW, Pagan NO, Ocasio MC, Ríos Z, Cubano LA, Boukli NM, Otero M, Hunter R, Nair MP, Rios-Olivares E.

Am J Infect Dis. 2007;3(4). doi: 10.3844/ajidsp.2007.267.275.

11.

Can non-lytic CD8+ T cells drive HIV-1 escape?

Seich Al Basatena NK, Chatzimichalis K, Graw F, Frost SD, Regoes RR, Asquith B.

PLoS Pathog. 2013;9(11):e1003656. doi: 10.1371/journal.ppat.1003656. Epub 2013 Nov 14.

12.

CD8(+) lymphocytes suppress human immunodeficiency virus 1 replication by secreting type I interferons.

Killian MS, Teque F, Walker RL, Meltzer PS, Killian JK.

J Interferon Cytokine Res. 2013 Nov;33(11):632-45. doi: 10.1089/jir.2012.0067. Epub 2013 Feb 12.

13.

Transcriptional profiling of experimental CD8(+) lymphocyte depletion in rhesus macaques infected with simian immunodeficiency virus SIVmac239.

Bosinger SE, Jochems SP, Folkner KA, Hayes TL, Klatt NR, Silvestri G.

J Virol. 2013 Jan;87(1):433-43. doi: 10.1128/JVI.01746-12. Epub 2012 Oct 24.

14.

Protein kinase C and NF-κB-dependent CD4 downregulation in macrophages induced by T cell-derived soluble factors: consequences for HIV-1 infection.

Raposo RA, Trudgian DC, Thomas B, van Wilgenburg B, Cowley SA, James W.

J Immunol. 2011 Jul 15;187(2):748-59. doi: 10.4049/jimmunol.1003678. Epub 2011 Jun 10.

15.

Virus-host interactions in HIV pathogenesis: directions for therapy.

Levy JA.

Adv Dent Res. 2011 Apr;23(1):13-8. doi: 10.1177/0022034511398874. Review.

16.

Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells.

Myoung J, Ganem D.

J Clin Invest. 2011 Mar;121(3):1130-40. doi: 10.1172/JCI43755. Epub 2011 Feb 21.

17.

Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells.

Killian MS, Johnson C, Teque F, Fujimura S, Levy JA.

J Virol. 2011 Feb;85(4):1696-705. doi: 10.1128/JVI.01120-10. Epub 2010 Dec 8.

18.

Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage.

Saunders KO, Ward-Caviness C, Schutte RJ, Freel SA, Overman RG, Thielman NM, Cunningham CK, Kepler TB, Tomaras GD.

Cell Immunol. 2011;266(2):154-64. doi: 10.1016/j.cellimm.2010.09.011. Epub 2010 Oct 27.

19.

Epigenetic regulation of CD8(+) T-lymphocyte mediated suppression of HIV-1 replication.

Saunders KO, Freel SA, Overman RG, Cunningham CK, Tomaras GD.

Virology. 2010 Sep 15;405(1):234-42. doi: 10.1016/j.virol.2010.06.001. Epub 2010 Jul 1.

20.

CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.

Klatt NR, Shudo E, Ortiz AM, Engram JC, Paiardini M, Lawson B, Miller MD, Else J, Pandrea I, Estes JD, Apetrei C, Schmitz JE, Ribeiro RM, Perelson AS, Silvestri G.

PLoS Pathog. 2010 Jan 29;6(1):e1000747. doi: 10.1371/journal.ppat.1000747.

Supplemental Content

Support Center